Showing results (31-40 of 94) with videos related to
Sort By:
Pageof 10
Therapeutic Advances in Neurological Disorders|August 29, 2024
Pattern of pareses in 5q-spinal muscular atrophyZeljko Uzelac, Beate Schwäble, Johannes Dorst, et al.European Journal of Neurology|November 17, 2023
Longitudinal course of neurofilament light chain levels in amyotrophic lateral sclerosis-insights from a completed randomized controlled trial with rasagilineSimon Witzel, Jeffrey M Statland, Petra Steinacker, et al.Eclinicalmedicine|December 14, 2019
Safety and efficacy of immunoadsorption versus plasma exchange in steroid-refractory relapse of multiple sclerosis and clinically isolated syndrome: A randomised, parallel-group, controlled trialJohannes Dorst, Tanja Fangerau, Daniela Taranu, et al.Journal of Neurology|December 26, 2015
Clinical features and differential diagnosis of flail arm syndromeAnnemarie Hübers, Viviane Hildebrandt, Susanne Petri, et al.Journal of Neurology, Neurosurgery, and Psychiatry|February 22, 2024
Primary lateral sclerosis: application and validation of the 2020 consensus diagnostic criteria in an expert opinion-based PLS cohortSimon Witzel, Veronika Micca, Hans P Müller, et al.Brain : a Journal of Neurology|May 14, 2024
Blood-CSF barrier integrity in amyotrophic lateral sclerosisVeronika Klose, Sarah Jesse, Jan Lewerenz, et al.Nutrients|May 27, 2026
Feasibility and Tolerability of Ketogenic Interventions in Amyotrophic Lateral Sclerosis-A Dose-Finding Case SeriesChristine Herrmann, Samantha Satari, Andrea Weber, et al.Journal of the Neurological Sciences|June 16, 2009
Linking neuron and skin: matrix metalloproteinases in amyotrophic lateral sclerosis (ALS)Lubin Fang, Friederike Huber-Abel, Marko Teuchert, et al.Journal of Neurology, Neurosurgery, and Psychiatry|August 21, 2021
Comparison of CSF and serum neurofilament light and heavy chain as differential diagnostic biomarkers for ALSSteffen Halbgebauer, Petra Steinacker, Federico Verde, et al.Translational Neurodegeneration|August 26, 2021
Neurofilament light and heterogeneity of disease progression in amyotrophic lateral sclerosis: development and validation of a prediction model to improve interventional trialsSimon Witzel, Felix Frauhammer, Petra Steinacker, et al.Pageof 10